Evolution of the Average Target: Xylem Inc.

Evolution of the Average Target - Xylem Inc.

Evolution of the Target Price: Xylem Inc.

Evolution of the Target Price - Xylem Inc.

Changes in Analyst Recommendations: Xylem Inc.

0836dadd1ba14c294cbaa115.9wuFnaNmyIR7DbFuHbqPIwtxHng11qO7JM2wLXb5VYc.o0Dj2dIcke86edxWeYnnZjI2fS8Fl-SLSqDdcjTJJPCHY8nklw2ntzhe_A~3c95cf273515c332f6605228fcd2fcdf
11-04 Argus Research Downgrades Xylem to Hold From Buy MT
11-02 Rothschild & Co Redburn Cuts Price Target on Xylem to $129 From $165 MT
11-02 Analyst recommendations: Adobe, Caterpillar, Fair Isaac, Regeneron Pharmaceuticals… Zonebourse
10-29 UBS Adjusts Xylem Price Target to $99 From $112, Maintains Neutral Rating MT
10-29 Not All AI Billions Are Equal Zonebourse
10-29 Barclays Downgrades Xylem to Equalweight From Overweight, Price Target is $104 MT
10-29 Analyst recommendations: Boston Scientific, Hilton, Kla Corporation, Fortinet, Microsoft… Zonebourse
10-28 Oppenheimer Adjusts Price Target on Xylem to $135 From $150, Maintains Outperform Rating MT
10-28 RBC Cuts Price Target on Xylem to $125 From $135, Keeps Outperform Rating MT
10-28 Citigroup Adjusts Price Target on Xylem to $130 From $148 MT
10-28 Analyst recommendations: Boeing, Qiagen, Spotify, Applovin, Fedex… Zonebourse
10-28 BNP Paribas Adjusts Price Target on Xylem to $135 From $145 MT
10-28 Goldman Sachs Adjusts Price Target on Xylem to $138 From $160 MT
10-28 JPMorgan Downgrades Xylem to Underweight From Neutral, $90 Price Target MT
10-19 JPMorgan Adjusts Price Target on Xylem to $118 From $137 MT
10-15 Mizuho Adjusts Price Target on Xylem to $110 From $130 MT
10-14 Xylem's YTD Stock Performance Reflects Fears Around Sustained Top-Line Pressure, Oppenheimer Says MT
10-14 Oppenheimer Adjusts Xylem Price Target to $150 From $158, Maintains Outperform Rating MT
10-14 RBC Capital Adjusts Xylem Price Target to $135 From $164, Maintains Outperform Rating MT
10-12 Citigroup Adjusts Price Target on Xylem to $148 From $172 MT
10-05 UBS Adjusts Price Target on Xylem to $112 From $138, Keeps Neutral Rating MT
10-01 BNP Paribas Adjusts Price Target on Xylem to $145 From $160, Maintains Outperform Rating MT
08-24 Jefferies Adjusts Price Target on Xylem to $150 From $145 MT
08-13 UBS Adjusts Price Target on Xylem to $138 From $135, Keeps Neutral Rating MT
08-12 Argus Adjusts Price Target on Xylem to $140 From $125, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+33.19%
+19.04%
+17.22%
-1.85%
-7.33%
+40.98%
+12.95%
+12.23%
+27.62%
+13.36%
Average +16.74%
Weighted average by Cap. +15.01%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
95.93USD
Average target price
125.44USD
Spread / Average Target
+30.76%
High Price Target
180.00USD
Spread / Highest target
+87.64%
Low Price Target
90.00USD
Spread / Lowest Target
-6.18%

Analyst Consensus Detail

Analyst consensus - Xylem Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Xylem Inc.
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Xylem Inc.
  1. Stock Market
  2. Stocks
  3. XYL Stock
  4. Consensus Xylem Inc.